AGENDA (with links to presentations and speakers)

MEETING NOTES

For notes and presentations from the community meeting with Bristol-Myers Squibb on Sunday, February 24, go to the BMS page.

Over 60 AIDS treatment activists attended the first teach-in. For many of them, it was their first regional or national meeting with other activists.

If you want to see any of the presentations from the teach-in, follow the links from the Agenda below. Presentations are in PowerPoint format. If you have questions on the presentations, you can ask your mentor, or e-mail the speaker (click on their name).

AGENDA

9:00 - 9:30 am Welcome and Introductions: Heidi Nass and Gregg Gonsalves Introduction to ATAC and CST

9:30 - 10:00 am Mentoring 101: Luther Brock, Julie Davids, Larry Diaz

10:00 - 11:15 am Drug Development

• Ben Cheng: Overview of Drug Development
• Yvette Delph: Drug Resistance and Pharmacokinetics

11:45 - 12:45 pm Data Interpretation: Gregg Gonsalves and Mark Harrington How to Look at Clinical Trials & Treatment Information

1:45 - 2:45 pm Drug Companies 101

• Jules Levin - Community Relationships with Pharmaceutical Companies
• Lynda Dee - A Perspective on Individual Medications

3:00 - 3:30 pm Drug Companies 201: Martin Delaney How to Prepare for a Drug Company Meeting

3:45 - 5:15 pm Drug Companies 301: Preparing for the meeting with Bristol-Myers Squibb

• Lynda Dee Discussion of Recent BMS Corporate Changes
• Martin Delaney Atazanavir Expanded Access program
• Bob Munk The DuPont Drug Pipeline
• Michael Marco Hepatitis B overview and Entecavir
• Yvette Delph Secure the Future (BMS International Activities)
• Martin Delaney Discussion of Recent BMS Price Increases

5:15 - 6:00 pm Mentoring 201 Discussion: Matt Sharp, Orlando Roman, Tracy Swan

MEETING NOTES prepared by Mark Baker (to come)

Revised March 4, 2002

Go to Main Page

E-mail the Coalition